A Post-Hoc Analysis of the Effect of Smoking Status on COPD Exacerbation Reductions with Budesonide/Glycopyrrolate/Formoterol Fumarate in Patients with COPD in the ETHOS Study

被引：0
作者：
Bafadhel, M. [1 ]
Han, M. K. [2 ]
Singh, D. [3 ]
Jenkins, M. [4 ]
Dorinsky, P. [5 ]
Patel, M. [4 ]
机构：
[1] Univ Oxford, Nuffield Dept Med, Resp Med Unit, Oxford, England
[2] Univ Michigan, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA
[3] Univ Manchester, Manchester Univ NHS Fdn Trust, Med Evaluat Unit, Manchester, Lancs, England
[4] AstraZeneca, Cambridge, England
[5] AstraZeneca, Durham, NC USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2022年 / 205卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1451
引用
收藏
页数：2
相关论文
共 50 条
[1]   Safety and Efficacy of Budesonide-Glycopyrrolate-Formoterol Fumarate for COPD in Black or African-American Patients: A Post-Hoc Subgroup Analysis of the ETHOS Study [J].
Han, M. K. ;
Jenkins, M. ;
Carstens, D. ;
Patel, M. ;
Feigler, N. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
[2]   A SCINTIGRAPHY STUDY OF BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL FUMARATE IN PATIENTS WITH COPD [J].
Usmani, Omar ;
Roche, Nicolas ;
Abd Wahab, Ezanul ;
Israel, Samuel ;
Jenkins, Martin ;
Trivedi, Roopa ;
Dorinsky, Paul ;
Aurivillius, Magnus .
CHEST, 2020, 158 (04) :2435A-2437A
[3]   Benefits of budesonide/glycopyrrolate/formoterol fumarate (BGF) on symptoms and quality of life in patients with COPD in the ETHOS trial [J].
Martinez, Fernando J. ;
Rabe, Klaus F. ;
Ferguson, Gary T. ;
Wedzicha, Jadwiga A. ;
Trivedi, Roopa ;
Jenkins, Martin ;
Darken, Patrick ;
Aurivillius, Magnus ;
Dorinsky, Paul .
RESPIRATORY MEDICINE, 2021, 185
[4]   Effect of Triple Inhaled Therapy With Budesonide/Glycopyrrolate/Formoterol Fumarate on Cardiopulmonary Events in Chronic Obstructive Pulmonary Disease: A Post-hoc Analysis of ETHOS [J].
Singh, D. ;
Martinez, F. J. ;
Hurst, J. R. ;
Han, M. K. ;
Gale, C. P. ;
Fredriksson, M. ;
Kisielewicz, D. ;
Mushunje, A. ;
Movitz, C. ;
Ojili, N. ;
Parikh, H. ;
Arya, N. ;
Bowen, K. ;
Patel, M. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
[5]   FUNCTIONAL RESPIRATORY IMAGING ASSESSMENT OF BUDESONIDE/GLYCOPYRROLATE/FORMOTEROL FUMARATE AND GLYCOPYRROLATE/FORMOTEROL FUMARATE METERED DOSE INHALERS IN PATIENTS WITH COPD [J].
van den Berge, M. ;
De Backer, Jan ;
Van Holsbeke, Cedric ;
De Backer, Wilfried ;
Trivedi, Roopa ;
Jenkins, Martin ;
Dorinsky, Paul ;
Aurivillius, Magnus .
CHEST, 2020, 158 (04) :1782A-1783A
[6]   Seasonal Variation in COPD Exacerbations: a Post-Hoc Analysis from the KRONOS Phase III Study of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) [J].
Rabe, K. F. ;
Fabbri, L. M. ;
Martinez, F. J. ;
Ferguson, G. T. ;
Bourne, E. ;
Darken, P. ;
DeAngelis, K. ;
Aurivillius, M. ;
Reisner, C. ;
Dorinsky, P. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
[7]   Seasonal Variation in COPD Exacerbations: a Post-Hoc Analysis from the KRONOS Phase III Study of Budesonide/Glycopyrrolate/ Formoterol Fumarate Metered Dose Inhaler (BGF MDI) [J].
Rabe, K. F. ;
Fabbri, L. M. ;
Martinez, F. J. ;
Ferguson, G. T. ;
Bourne, E. ;
Darken, P. ;
DeAngelis, K. ;
Aurivillius, M. ;
Reisner, C. ;
Dorinsky, P. .
PNEUMOLOGIE, 2020, 74 :S44-S44
[8]   Benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate on lung function and exacerbations of COPD: a post-hoc analysis of the KRONOS study by blood eosinophil level and exacerbation history [J].
Muro, Shigeo ;
Kawayama, Tomotaka ;
Sugiura, Hisatoshi ;
Seki, Munehiro ;
Duncan, Elizabeth A. ;
Bowen, Karin ;
Marshall, Jonathan ;
Megally, Ayman ;
Patel, Mehul .
RESPIRATORY RESEARCH, 2024, 25 (01)
[9]   Benefits of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler in Patients with Chronic Obstructive Pulmonary Disease by Baseline CAT Score: Post-Hoc Analysis of the ETHOS Study [J].
Hurst, J. ;
Martinez, F. J. ;
Singh, D. ;
Darken, P. ;
Patel, M. ;
Dorinsky, P. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
[10]   Benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate triple therapy versus dual therapies in patients with COPD and additional asthma features: Post-hoc analysis of KRONOS and ETHOS [J].
Seki, Munehiro ;
Muro, Shigeo ;
Hurst, John R. ;
Petullo, David ;
Darken, Patrick ;
Megally, Ayman ;
Patel, Mehul .
RESPIROLOGY, 2023, 28 :126-127
12345